These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 18268482)

  • 1. Is there overlap in blood-pressure response to the blockers of the renin-angiotensin system between lower and higher renin subjects?
    Minami J; Ishimitsu T; Matsuoka H
    Am J Hypertens; 2008 Feb; 21(2):130-1; author reply 132. PubMed ID: 18268482
    [No Abstract]   [Full Text] [Related]  

  • 2. Antihypertensive pharmacological agents: beyond their lowering blood pressure effects.
    Miatello RM
    Cell Mol Biol (Noisy-le-grand); 2005 Nov; 51(6):521-3. PubMed ID: 16309575
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of antihypertensive treatment based on plasma renin activity: An open label observational study.
    Leotta G; Rabbia F; Testa E; Totaro S; Abram S; Milan A; Mulatero P; Veglio F
    Blood Press; 2010 Aug; 19(4):218-24. PubMed ID: 20367559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of sleep blood pressure.
    Morgan TO
    Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):803-9. PubMed ID: 20528638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of renin in blood pressure regulation and therapeutic potential of renin inhibition.
    Ferro A; Gilbert R; Krum H
    Int J Clin Pract; 2006 May; 60(5):577-81. PubMed ID: 16700858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin angiotensin system inhibition in the older person: a review.
    Mohamed MA; Weir MR
    Clin Geriatr Med; 2009 May; 25(2):245-57. PubMed ID: 19555871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment levels of plasma renin activity predict ambulatory blood pressure response to valsartan in essential hypertension.
    Minami J; Ohno E; Furukata S; Ishimitsu T; Matsuoka H
    J Hum Hypertens; 2009 Oct; 23(10):683-6. PubMed ID: 19369955
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood and hypertension: the damage of too much pressure.
    Casey G
    Nurs N Z; 2011 Sep; 17(8):26-31. PubMed ID: 22096822
    [No Abstract]   [Full Text] [Related]  

  • 9. Defining the role of renin/angiotensin-targeted antihypertensive therapy in decreasing cardiovascular risk: evidence, guideline evolution, and questions to be resolved.
    Probstfield J
    J Fam Pract; 2009 Jun; 58(6 Suppl):S1-8. PubMed ID: 19508849
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hypertension combination therapy with renin-angiotensin system blockers].
    Soucek M
    Vnitr Lek; 2009 Sep; 55(9):719-23. PubMed ID: 19785368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel drugs targeting hypertension: renin inhibitors and beyond.
    Leibovitz E; Schiffrin EL
    J Cardiovasc Pharmacol; 2007 Jul; 50(1):3-8. PubMed ID: 17666909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laragh's lessons in pathophysiology and clinical pearls for treating hypertension.
    Laragh J
    Am J Hypertens; 2001 Jun; 14(6 Pt 1):491-503. PubMed ID: 11411727
    [No Abstract]   [Full Text] [Related]  

  • 13. A common polymorphism in the renin angiotensin system is associated with differential outcome of antihypertensive pharmacotherapy prescribed to Brazilian older women.
    Moraes CF; Souza ER; Souza VC; Medeiros EF; Gonçalves TF; Toledo JO; Karnikowski M; Gomes L; Karnikowski MG; Córdova C; Nóbrega OT
    Clin Chim Acta; 2008 Oct; 396(1-2):70-5. PubMed ID: 18657531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypertensive treatment in light of the latest discoveries in the renin-angiotensin system].
    Traub Y
    Harefuah; 1996 Feb; 130(3):195-9. PubMed ID: 8682399
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of pharmacological modulation of the renin-angiotensin-aldosterone system on salt sensitivity in patients with borderline hypertension.
    Borghi C; Boschi S; Costa FV; Bacchelli S; Degli Esposti D; Piccoli M; Ambrosioni E
    J Hypertens Suppl; 1993 Dec; 11(5):S248-9. PubMed ID: 8158368
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibiting the renin-angiotensin system: why and in which patients.
    Berra K; Miller NH
    J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of the plasma renin hormonal control system that regulates blood pressure and sodium balance for correctly treating hypertension and for evaluating ALLHAT.
    Laragh JH; Sealey JE
    Am J Hypertens; 2003 May; 16(5 Pt 1):407-15. PubMed ID: 12745204
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood pressure lowering effects of niacin-bound chromium(III) (NBC) in sucrose-fed rats: renin-angiotensin system.
    Perricone NV; Bagchi D; Echard B; Preuss HG
    J Inorg Biochem; 2008 Jul; 102(7):1541-8. PubMed ID: 18374418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of blood pressure control in a population with a growing girth.
    Bakris GL
    Curr Opin Nephrol Hypertens; 2009 Sep; 18(5):379-80. PubMed ID: 19623066
    [No Abstract]   [Full Text] [Related]  

  • 20. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.